Quality assurance for the EORTC 22071–26071 study: dummy run prospective analysis

PURPOSE: The phase III 22071–26071 trial was designed to evaluate the addition of panitumumab to adjuvant chemotherapy plus intensity modulated radiotherapy (IMRT) in locally advanced resected squamous cell head and neck cancer. We report the results of the dummy run (DR) performed to detect deviati...

Descripción completa

Detalles Bibliográficos
Autores principales: Fairchild, Alysa, Langendijk, Johannes A, Nuyts, Sandra, Scrase, Christopher, Tomsej, Milan, Schuring, Danny, Gulyban, Akos, Ghosh, Sunita, Weber, Damien C, Budach, Wilfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311463/
https://www.ncbi.nlm.nih.gov/pubmed/25424399
http://dx.doi.org/10.1186/s13014-014-0248-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311463/
https://www.ncbi.nlm.nih.gov/pubmed/25424399
http://dx.doi.org/10.1186/s13014-014-0248-9

Ejemplares similares